Related Experiment Video
Updated: May 24, 2025
Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
Heart transplant as treatment for cardiogenic shock: an effective strategy or a "Spanish exception"?
Francisco José Hernández-Pérez1, Alba Martín-Centellas1, Mercedes Rivas-Lasarte1
1Unidad de Insuficiencia Cardiaca Avanzada y Trasplante, Servicio de Cardiología, Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, Spain; Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana (IDIPHISA), Madrid, Spain.
Insights
Cardiogenic shock management in Spain faces equity challenges in heart transplantation. Alternatives like ventricular assist devices and expanded donor criteria are crucial for improving patient outcomes.
Area of Science:
- Cardiovascular Medicine
- Transplantation Immunology
- Medical Ethics
Background:
- Cardiogenic shock presents a significant challenge in cardiovascular medicine.
- Urgent cardiac transplantation is the primary heart replacement therapy in Spain for eligible patients lacking cardiac recovery.
- Current transplantation practices raise equity concerns regarding recipient, donor, and organ access factors.
Purpose of the Study:
- To analyze the challenges and equity implications of cardiac transplantation in Spain.
- To explore alternative strategies for managing cardiogenic shock and organ scarcity.
- To discuss the evolving criteria for organ distribution in cardiovascular medicine.
Main Methods:
- Review of current practices in cardiac transplantation and cardiogenic shock management in Spain.
- Analysis of ethical considerations related to organ allocation and recipient selection.
- Evaluation of alternative therapies, including left ventricular assist devices (LVADs).
Main Results:
- Recipient selection must prioritize multiorgan failure before considering transplantation.
- Expanding the donor pool, potentially with suboptimal organs, is essential to meet demand.
- Long-term LVADs offer a viable alternative to transplantation due to donor scarcity.
Conclusions:
- Organ distribution criteria require continuous evolution to balance individual benefit with the common good.
- Addressing equity in cardiac transplantation necessitates a multifaceted approach.
- Ventricular assist devices represent a critical alternative in the context of limited donor availability.
Abstract:
Cardiogenic shock remains one of the main challenges in modern cardiovascular medicine. In Spain, urgent cardiac transplantation is the most widely used heart replacement therapy fin eligible patients who do not achieve cardiac recovery. However, this approach has significant implications related to the principle of equity, influenced by the characteristics of the recipient, the donor, and organ access. When selecting a recipient, multiorgan failure must first be addressed before considering transplantation. At the same time, it is essential to expand the donor pool through various strategies to meet the growing demand, even if it involves using suboptimal organs. Given the scarcity of donors and favorable outcomes, long-term left ventricular assist devices should be considered as an alternative to transplantation. Finally, designing organ distribution criteria remains a constantly evolving challenge, as there is no universal system that can address all the issues involved. Allocating organs to the most critically ill patients can provide substantial individual benefits, as long as it does not significantly compromise the common good.
